Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Wave Life Sciences Ltd. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $100 Billion
- Q4 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 17,109 shares of WVE stock, worth $181,355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,109
Previous 41,620
58.89%
Holding current value
$181,355
Previous $341,000
38.12%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding WVE
# of Institutions
191Shares Held
122MCall Options Held
430KPut Options Held
330K-
Ra Capital Management, L.P. Boston, MA18.2MShares$193 Million3.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.62MShares$102 Million0.22% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$87.6 Million1.98% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$71.4 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.71MShares$71.2 Million0.81% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $920M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...